Document Detail

Vaccines for pneumonia and new antiviral therapies.
MedLine Citation:
PMID:  11680115     Owner:  NLM     Status:  MEDLINE    
Influenza and pneumococcal diseases are preventable to a large extent. The Health Care Financing Agency of Medicare and the Joint Commission on Accreditation of Healthcare Organizations have made prevention of these two diseases a top priority. Immunization should remain the primary tool for prevention. When influenza epidemics appear, practitioners should be aware that effective drugs are available to treat influenza A or B if given promptly after the onset of illness.
P A Gross
Related Documents :
18797535 - New 45-49 year health checks - gp uptake of mbs item 717.
11503685 - Health care perceptions and experiences.
16816285 - Managing medicaid behavioral health care: findings of a national survey in the year 2000.
9921735 - State insurance commissioner actions against health maintenance organizations for denia...
24324995 - English literacy as a barrier to health care information for deaf people who use auslan.
7923535 - Clinical immunology--guidelines for organization, training and certification: memorandu...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Medical clinics of North America     Volume:  85     ISSN:  0025-7125     ISO Abbreviation:  Med. Clin. North Am.     Publication Date:  2001 Nov 
Date Detail:
Created Date:  2001-10-26     Completed Date:  2001-12-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  2985236R     Medline TA:  Med Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1531-44     Citation Subset:  AIM; IM    
Department of Internal Medicine, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acetamides / therapeutic use
Amantadine / therapeutic use
Antiviral Agents / adverse effects,  therapeutic use*
Centers for Medicare and Medicaid Services (U.S.)
Health Priorities
Influenza Vaccines
Joint Commission on Accreditation of Healthcare Organizations
Neuraminidase / antagonists & inhibitors
Patient Selection
Pneumococcal Vaccines
Pneumonia / epidemiology,  immunology,  prevention & control*
Primary Prevention / methods
Rimantadine / therapeutic use
Sialic Acids / therapeutic use
United States / epidemiology
Vaccination / adverse effects,  methods*
World Health
Reg. No./Substance:
0/Acetamides; 0/Antiviral Agents; 0/Guanidines; 0/Influenza Vaccines; 0/Oseltamivir; 0/Pneumococcal Vaccines; 0/Pyrans; 0/Sialic Acids; 13392-28-4/Rimantadine; 139110-80-8/Zanamivir; 768-94-5/Amantadine; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nonresolving pneumonia and mimics of pneumonia.
Next Document:  Risk factors for nosocomial pneumonia. Focus on prophylaxis.